Wei Ding
@WeiDing3
Followers
369
Following
941
Media
8
Statuses
143
Hematologist, cancer researcher, Mayo clinic, Rochester
Minnesota, USA
Joined December 2013
@PrajishIyer will also be presenting a poster on identification of T cell subsets using single-cell sequencing that predict chemo sensitivity in RT. This work was done in collaboration with @WeiDing3 and others @MayoClinic! #ASH23 #lymphoma
https://t.co/yCKv8hpaxl
1
2
4
The most important CLL study present at ASCO this year. Caution for triplets therapy.
Jennifer A. Woyach, MD, on New Findings on CLL, COVID-19, and Treatment With Obinutuzumab Plus Venetoclax https://t.co/tmZpdoozS3
#leusm #leukemia #COVID19 #hematology #ASCO23 @OSUCCC_James
0
0
5
Glad we got this open
MIRACLE, an investigator-initiated study of MRD-guided, time-limited frontline therapy with pirtobrutinib and venetoclax for CLL/SLL, sponsored by @LoxoLillyOnc, is now open @MayoCancerCare. https://t.co/v39xNZxi3H
0
0
2
Happy Chinese Year of the Rabbit! Looking forward to a wonderful new year of research and fantastic new discoveries.
0
2
13
Wonderful presidential symposium, thanks for putting it together!#ASH21
#ASHKudos to 2021 ASH President @MartinTallman!
0
0
3
Congrats for Steve’s outstanding contribution for clinical translational discovery using PD-1 antibody to treat Hodgkin lymphoma- Ernst Beutler award!
Congratulations to Dr. Stephen Ansell for being awarded the Ernst Beutler Prize for his clinical and translational work on PD-1 in Hodgkin lymphoma #ASH21 @MayoCancerCare
0
1
5
Congrats for our senior fellow Dr. Hampel’s wonderful presentation!
Great day 2 at #iwCLL2021 and thankful for the opportunity to present our study on post ibrutinib progression outcomes. Incredible (virtual) international gathering of people dedicated to improving care of patients w/ CLL @sparikhmd @WeiDing3 @neilkay15 @kenderian_ss @hemepa_c
0
0
4
The CLL International Prognostic Index predicts outcomes in monoclonal B-cell lymphocytosis and Rai 0 CLL https://t.co/6gOr0XGATv
0
0
1
Glad to see mayo clinic celebrate international women’s day with our successful mayo women physician and scientists!
In honor of International Womens Day on March 8, meet eight (of many) trailblazing women in Mayo Clinic's Center for Individualized Medicine: https://t.co/JqRWExboUE
#IWD2021 #ChooseToChallenge
0
0
4
Ox typically implicates strong move and finish, let us hope this is a positive and recover year!
1
0
5
The vaccine wars!
As #vaccines for #covid19 are distributed all across the globe, we look back at this data visualization from 2017 that illustrates the power of vaccines to vanquish disease—an impact that far eclipses their minute risks. 👉 https://t.co/sFPgOS3imm
0
0
3
Excellent presentation and work by Dr. Phase Benjamini, CART for RT, 6/9 CR for heavily double refractory CLL to RT patients. Still relapses after CR to CART. But good intermediate for allo?
0
0
3
Exciting new therapy option, excellent talk.
0
0
3
Amazing result for bispecific. @sparikhmd possible good option for RT.
@YucaiWangMD Particularly amazed with this SubQ option.
1
0
2
Glad to see the collaboration for novel combination using the idea of novel synthetic lethality nicely presented by Dr. Mato @anthonymatomd
DTRM-555, synthetic lethality based BTKi/mTORi/IMiD triplet pill, promising activity in heavily pretreated Richter and de novo DLBCL. Ph2 ongoing. @anthonymatomd @WeiDing3 @DtrmWeihe
0
1
2
Prajish's work in collaboration with @WeiDing3 and @MayoClinic has been very fruitful. This finding may hopefully lead to additional studies on Treg functions and inform future clinical decisions with regards to immune checkpoint inhibitors.
0
3
8
I am very glad that we collaborate on this project and congrats for excellent work @LiliWangLab @PrajishIyer
I am excited to announce that @PrajishIyer from my lab has won the ASH Abstract Achievement Award. Prajish worked very hard on this project with @WeiDing3 and @MayoClinic. I could not be more proud of him. #ASH20 #hematology #Lymphoma
1
0
2
Indeed excellent review of CLL in NEJM
Great to see not just one, but two articles on CLL in today's @NEJM ! 1. Review of Treatment in CLL: https://t.co/q3QWHeMZwW 2. Longer term follow-up of ibrutinib in patients with TP53 alterations in CLL:
0
0
5
Indeed super cool!
Check out https://t.co/wtCEP4eHcw for uniformly processed and annotated tumor @scRNAseq data of > 2M cells! Very nice visualization and user-friendly features.
0
0
1
What would you do?
72 yo asymptomatic male with previously untreated Rai IV CLL to begin single-agent BTKi therapy. Prior to starting BTKi, which of the following tests will you do? @NitinJainMD @anthonymatomd @DrMDavids @mshadman @kenderian_ss @WeiDing3 @neilkay15
0
0
1